OnCo
trialsTrialCompleted

Study of Azacitidine,Venetoclax,and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients

A phase 2 trial of Azacitidine, Venetoclax and Flumatinib in Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic myeloid leukaemia and Leukaemia, run by The First Affiliated Hospital of Soochow University, completed.